Recent articles
Here's Why Dermira Stock Is Rocketing Higher Today
The company gave investors a closer look at its eczema candidate and they liked what they saw.
Here's Why Assembly Biosciences Jumped Again on Thursday
Investors digesting a late-breaking data drop pushed up the stock.
Are These 3 Beaten-Down Biotech Stocks Bargains Now?
Some investors think the market's been too hard on these drugmakers.
3 Dividend-Paying Pharma Stocks to Buy Now
These aren't the highest payouts in the industry, but they have the best chance to steadily climb.
Can Organigram Holdings Double Your Money?
A bullish Wall Street analyst thinks it can.
3 Big Pharma Companies Driving Price Inflation
Could these biopharmaceutical giants continue growing if they stopped hiking up drug prices?
3 Blindness-Fighting Biotech Stocks That Could Surge This Week
Here's what to look out for at the American Academy of Ophthalmology's annual meeting later this week.
3 Healthcare Stocks Perfect for Retirees
These aren't the most exciting businesses in the sector, but you're going to love their steadily growing dividends.
3 Top Healthcare Stocks to Buy in October
These three healthcare pioneers have slid down to nice prices that investors should take advantage of this month.
Here's Why Aimmune Therapeutics Stock Jumped on Wednesday
A survey of allergists suggests Palforzia's launch could be more successful than expected.
3 Top Biotech Stocks to Buy in October
These small-cap biotechs have fallen to bargain prices.
Here's Why AnaptysBio Stock Fell on Tuesday
The company released some positive data yesterday...that wasn't positive enough.
3 Marijuana Stocks Ready for a Cash Crunch
These are the companies best positioned to survive a bear attack.
Here's Why Dova Pharmaceuticals Stock Is Rocketing Higher Today
Stockholm-based Sobi wants to expand its U.S. presence, beginning with Dova's platelet therapy.
Will the Big Canadian Pot Producers Miss Expectations Again?
Here's why a fearless marijuana stock analyst thinks investors are still too optimistic about the next two years.
Where Will Pfizer Be in 5 Years?
America's largest pharmaceutical company is going through some big changes.
How Worried Should Teledoc Be About Amazon's Latest Move?
Amazon's new pilot program looks like a shot across the bow of Teledoc and its peers.
Here's Why TherapeuticsMD Stock Bounded Higher on Wednesday
August sales figures suggest the company's strategy is working.
Is Veeva Systems a Buy on the Dip?
Is it time to take advantage of a recent pullback, or is this a falling knife you don't want to catch?
Here's Why BioCryst Pharmaceuticals Popped Today
Investors are thrilled with a new addition to BioCryst's board of directors.